VIEWPOINTS Martin Kilsgård, Head of Product at Trialbee, Shares Insights from the Launch of Trialbee Honey™ Analytics at DPHARM 2022BySenior EditorNovember 2, 20220Comments
VIEWPOINTS Natalie Shiff, Associate Medical Director, Janssen Rheumatology Shares Insights from the FDA Approval of Stelara to Treat Pediatric Patients with Active Psoriatic ArthritisBySenior EditorOctober 31, 20220Comments
INSIGHTS+ Top Performing Drug of 2021 – Biktarvy (October Edition)BySenior EditorOctober 27, 20220Comments
INSIGHTS+ Insights+: EMA Marketing Authorization of New Drugs in September 2022BySenior EditorOctober 26, 20220Comments
VIEWPOINTS Garret Hampton, President, Clinical Sequencing & Oncology at Thermo Fisher Scientific Shares Insights from the Approval of the First NGS-Based Companion Diagnostic for HER2-Mutant NSCLCBySenior EditorOctober 25, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in September 2022BySenior EditorOctober 20, 20220Comments
VIEWPOINTS Josh Rubel, CCO at MDClone, Shares Insights on the Partnership with MCI Onehealth to Accelerate Research through Global Clinical Intelligence OfferingBySenior EditorOctober 19, 20220Comments
